• Twitter
  • Facebook
  • LinkedIn
Biweekly newsletter of the International Cytokine & Interferon Society

Biweekly newsletter of the International Cytokine & Interferon Society

Signals+ Editors: Daniella Schwartz & Di Yu (Editors in Chief), Saurabh Chattopadhyay, Zhian Chen, Mohamed Saad & Maialen Sebastian-delaCruz
  • Subscribe
  • Archives
    • Archives (Oct. 2022 and before)
  • Awards
  • Annual Meeting
  • Member News
    • Member Highlights
    • Members in the News
    • Members on the Move
    • New Member Mini-Bios
    • Articles of Interest
    • Reviews of Interest
  • Society News
    • President’s Letter
    • Featured Article!
  • Industry News
    • Industry Partner News
    • Other Meetings
    • Clinical Trials
HomeSignals+ PDFPast Issue PDFsSignals+ April 2021 PDF

Signals+ April 2021 PDF

April 12, 2021 Past Issue PDFs

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Previous

Signals+ Archive from October 2020 – the Inaugural Issue in 1994

Next

A NOTE FROM THE OUTGOING PRESIDENT, Kate Fitzgerald:

President's Message Banner
President's Letter

Going for Gold: The Olympic Spirit of Cytokine Science

March 1, 2026

The Winter Olympics brought a much-needed mental break during a February- the middle of Northwestern’s Winter Quarter, a respite from undergraduate teaching, grant writing, and the pandemonium of ongoing political noise. The beauty of the snowy Milan-Cortino mountains of was a perfect backdrop to the gathering of outstanding athletes from [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Photo of Anna Dittrich on a cold, windy beach
Member Highlights

From Düsseldorf to Tokyo — and Back to IL-6: Meet Anna Dittrich

March 1, 2026

I´m a biologist by training and currently work as a senior researcher at the Otto von Guericke University Magdeburg, Germany. My research focuses on understanding how intracellular cytokine-induced signaling robustly encodes and transmits information, with a special focus on my favorite cytokine IL-6. Please tell us your name, degree, where [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Clinical Trials

Concentrations of Pro-inflammatory and Anti-inflammatory Cytokines and Metallopeptidases in the Serum During the Treatment of Pain Caused by Bulging of the Intervertebral Disc in the Lumbar Spine

March 1, 2026

Concentrations of Pro-inflammatory and Anti-inflammatory Cytokines and Metallopeptidases in the Serum During the Treatment of Pain Caused by Bulging of the Intervertebral Disc in the Lumbar Spine ClinicalTrials.gov ID NCT06545812 Sponsor: Josip Juraj Strossmayer, University of Osijek Information provided: by Karla Rožac, Josip Juraj Strossmayer, University of Osijek (Responsible Party) [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Clinical Trials

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

March 1, 2026

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia ClinicalTrials.gov ID NCT05600920 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Information provided by: National Institutes of Health Clinical Center (CC) (National Institute of Allergy and Infectious Diseases (NIAID)) (Responsible Party) Last Update [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Clinical Trials

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

March 1, 2026

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23) ClinicalTrials.gov ID NCT06792487 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Information provided by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Responsible Party) Last Update Posted: 2025-01-24 Brief Summary Psoriasis is an immune-mediated inflammatory skin disease characterized by the presence [READ MORE]

Share this:

  • Click to share on Bluesky (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy

Go to mobile version
 

Loading Comments...